These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6977973)

  • 1. Plasma lipid concentrations and lecithin: cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
    Heller F; Desager JP; Harvengt C
    Acta Cardiol Suppl; 1981; 27():103-6. PubMed ID: 6977973
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
    Heller FR; Desager JP; Harvengt C
    Metabolism; 1981 Jan; 30(1):67-71. PubMed ID: 7464555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
    Heller FR; Desager JP; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of fenofibrate (author's transl)].
    Kritchevsky D
    Nouv Presse Med; 1980 Dec; 9(49):3769-73. PubMed ID: 7208345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking on serum lipid and lipoprotein concentrations and lecithin: cholesterol acyltransferase activity.
    Dirican M; Sarandöl E; Ulukaya E; Tokullugil HA
    J Med Invest; 1999 Aug; 46(3-4):169-72. PubMed ID: 10687311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity.
    Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
    J Physiol Pharmacol; 2002 Sep; 53(3):463-75. PubMed ID: 12369742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How does fenofibrate exert its cholesterol-lowering effect? (author's transl)].
    Wülfert E
    Nouv Presse Med; 1980 Dec; 9(49):3733-6. PubMed ID: 7208339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of fenofibrate on blood platelet functions (author's transl)].
    Renaud S; Dumont E; Drouin P; Debry G
    Nouv Presse Med; 1980 Dec; 9(49):3763-7. PubMed ID: 7208344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin: cholesterol acyltransferase activity in relation to plasma lipids in young Brazilian men.
    Gillett MP; de Oliveira DN; Owen JS
    Rev Bras Biol; 1978 Aug; 38(3):683-8. PubMed ID: 358311
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus.
    Vrablík M; Dobiásová M; Stulc T; Kasalová Z; Dolezalová R; Prázný M; Fait T; Ceska R
    Neuro Endocrinol Lett; 2008 Feb; 29(1):146-50. PubMed ID: 18283261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
    Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
    Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease].
    Márk L; Márki-Zay J; Orosz I; Kondacs A; Erdei F; Katona A
    Orv Hetil; 2003 Apr; 144(16):765-8. PubMed ID: 12778627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of fenofibrate on the lipid level in diabetic patients].
    Häring HU; Schleicher E; Renner R; Mehnert H
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):751-3. PubMed ID: 6415427
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum lipids and lecithin cholesterol acyltransferase activity in chronic hemodialysis patients (author's transl)].
    Makise J; Matsuda Y; Hirose N; Hara K; Kijima Y; Shoji T; Kanayama M
    Rinsho Byori; 1979 Mar; 27(3):233-6. PubMed ID: 439472
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of lecithin-cholesterol acyltransferase in normolipidemic and dyslipidemic plasma.
    Cheung MC
    Int J Clin Lab Res; 1993; 23(1):30-3. PubMed ID: 8477088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pravastatin on lipid transfer protein and lecithin cholesterol acyltransferase in heterozygous familial hypercholesterolemia.
    Fusegawa Y; Tada H; Oguma T; Shiina Y; Moriguchi EH; Tanabe T; Tamachi H; Tomoda H; Goto Y
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):81-6. PubMed ID: 7701533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: a comparison with fenofibrate.
    Harnafi H; Bouanani Nel H; Aziz M; Serghini Caid H; Ghalim N; Amrani S
    J Ethnopharmacol; 2007 Jan; 109(1):156-60. PubMed ID: 17092671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.